These interactive effects between PLA2G7 V279F and baseline BMI indicate that the approximately 32% lower Lp-PLA2 activity detected in the PLA2G7 279F allele carriers might offer certain protection against hypertension, even in the case of persistent overweight for over three years. The gene discussed is PLA2G7; the disease is hypertensive disorder.